SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-321781
Filing Date
2021-11-05
Accepted
2021-11-05 17:22:44
Documents
16
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d250065d10ka.htm   iXBRL 10-K/A 46824
2 EX-31.1 d250065dex311.htm EX-31.1 10854
3 EX-31.2 d250065dex312.htm EX-31.2 10867
  Complete submission text file 0001193125-21-321781.txt   250887

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA logc-20201231.xsd EX-101.SCH 4674
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20201231_cal.xml EX-101.CAL 676
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20201231_def.xml EX-101.DEF 1681
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20201231_lab.xml EX-101.LAB 20926
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20201231_pre.xml EX-101.PRE 16595
9 EXTRACTED XBRL INSTANCE DOCUMENT d250065d10ka_htm.xml XML 5758
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38707 | Film No.: 211385764
SIC: 2836 Biological Products, (No Diagnostic Substances)